Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) issued its earnings results on Wednesday. The technology company reported $0.58 earnings per share (EPS) for the quarter, Zacks reports. The firm had revenue of $66.32 million for the quarter. Kewaunee Scientific had a return on equity of 14.10% and a net margin of 3.41%.
Kewaunee Scientific Price Performance
Shares of KEQU stock opened at $35.03 on Thursday. Kewaunee Scientific has a 12-month low of $33.27 and a 12-month high of $57.88. The firm has a market capitalization of $100.54 million, a price-to-earnings ratio of 10.88 and a beta of 0.73. The company has a quick ratio of 1.55, a current ratio of 2.18 and a debt-to-equity ratio of 0.53. The firm has a fifty day moving average of $36.73 and a 200-day moving average of $37.14.
Institutional Trading of Kewaunee Scientific
Hedge funds have recently added to or reduced their stakes in the business. Bank of America Corp DE grew its stake in Kewaunee Scientific by 2,605.9% in the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock valued at $28,000 after acquiring an additional 443 shares during the period. US Bancorp DE increased its holdings in shares of Kewaunee Scientific by 80.0% in the third quarter. US Bancorp DE now owns 900 shares of the technology company’s stock worth $38,000 after acquiring an additional 400 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Kewaunee Scientific during the second quarter worth about $60,000. Barclays PLC acquired a new stake in shares of Kewaunee Scientific during the fourth quarter worth about $92,000. Finally, Mink Brook Asset Management LLC bought a new position in shares of Kewaunee Scientific during the 2nd quarter valued at about $370,000. Institutional investors and hedge funds own 32.69% of the company’s stock.
Analysts Set New Price Targets
Check Out Our Latest Research Report on KEQU
About Kewaunee Scientific
Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.
The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.
Further Reading
- Five stocks we like better than Kewaunee Scientific
- Sezzle’s BNPL Growth Is Working, But the Stock Comes With a Catch
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
